# Memantine Hydrochloride in Helping Cancer Survivors Stop Smoking

> **NCT01535040** · PHASE2 · COMPLETED · sponsor: **Wake Forest University Health Sciences** · enrollment: 130 (actual)

## Conditions studied

- Breast Cancer
- Colorectal Cancer
- Lung Cancer
- Prostate Cancer
- Tobacco Use Disorder

## Interventions

- **DRUG:** memantine hydrochloride
- **DRUG:** placebo

## Key facts

- **NCT ID:** NCT01535040
- **Lead sponsor:** Wake Forest University Health Sciences
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-08-01
- **Primary completion:** 2014-02-01
- **Final completion:** 2014-02-01
- **Target enrollment:** 130 (ACTUAL)
- **Last updated:** 2021-09-28

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01535040

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01535040, "Memantine Hydrochloride in Helping Cancer Survivors Stop Smoking". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT01535040. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*